WHAT YOU ALREADY DO
Filled → reminder → outreach call → gap in therapy flagged
All of it downstream of somebody who never understood it in the first place.
WHY MEMBERS STOP
Your programs already address the barriers everybody knows about — copay support, ninety-day fills, synchronisation, refill outreach, medication therapy management; every one of them assumes the member knows what they are taking and why, and most of the time they do not.
WHAT YOU ALREADY DO
Filled → reminder → outreach call → gap in therapy flagged
All of it downstream of somebody who never understood it in the first place.
WHAT SITS UNDERNEATH
Filled → understood → expected effects recognised → still taking it in week three
And a comprehension score per member, per medication, per language.
WHAT IT PRODUCES THAT YOU DO NOT HAVE
COMPREHENSION
Two questions after every lesson. Not a completion tick — an answer. Reported by medication, by language, by cohort.
THE MISS
Not just that comprehension was low, but which idea failed and what they believed instead. Nobody in this industry has that.
LANGUAGE
Read aloud, in the language the member speaks at home, with no interpreter line, no scheduling and no coordinator.
NO PHI
The code carries the medication, never the person. No member file, no roster, no business associate agreement on the described flow.
WHAT IT COSTS YOU TO RUN
No development, no engineering time, no roadmap slot, no vendor integration project, no clinical system to connect to.
No support desk, no staff to hire, no training programme, no content team, no annual review cycle.
No app, no account, no member portal, no billing to run, and no protected health information to secure.
It already exists. You switch it on for a population and it runs.
In retail this is sold per scan with an optional patient subscription, and that model is wrong for a book of business; here it is per member per month across a defined population, and a targeted cohort — members on chronic therapy — is where most of these would start.
THE PROPOSITION
Every vendor who writes to you opens with an adherence figure; we are opening by refusing to give you one, because we have not earned it yet and your clinical team would take it apart in a meeting.
WHAT WE ARE ACTUALLY ASKING FOR
Ninety days, one cohort, one therapeutic class, one measure that already sits in your reporting; we deliver the education and report comprehension, and you measure everything else using the instrument you already use.
WE REPORT
Delivery, completion, and the two questions answered — by medication, language and cohort. Weekly. Yours whether or not this continues.
YOU REPORT
Persistence, PDC, refill timing, gaps in therapy — whichever you already track, against the same cohort's prior period.
NOBODY REPORTS
No adherence claim, no cost-avoidance model, no projected outcome. If it does not move, you will know in ninety days.
CHANGE IN THE MEASURE YOU CHOSE
—
That box is empty on purpose; filling it is the point of the ninety days, and it is the only claim we would ever make about this.
THE ASK
Thirty minutes with whoever owns adherence and whoever owns clinical outcomes, in the same room; we will show the lesson for a medication your book actually covers, in English and Spanish, before you decide anything.
PROPOSE A MEASUREMENT